Revenue recognition (Tables)

12 Months Ended

Dec. 31, 2024

Revenue from Contract with Customer [Abstract]

Schedule of Revenues by Geographic Region

The Company’s net revenues by geographic region, based on the patient’s location are summarized as follows:

	Year ended December 31,
	2024		2023		2022
United States	$	391,801	$	349,743	$	406,894
International markets:
Germany	65,263		60,210		46,120
France	55,730		11,736		—
Japan	32,569		31,668		32,781
Other international markets	42,471		32,757		30,713
International markets - Total	196,033		136,371		109,614
Greater China (1)	17,386		23,224		21,332
Total net revenues	$	605,220	$	509,338	$	537,840

(1)    For additional information, see c below.

Schedule of Revenue Recognized According Performance Period

The company's net revenues by performance period are as follows:

	Year ended December 31,
	2024		2023		2022
Net revenues recognized in the reporting period from performance obligations satisfied in:
Reporting period	$	568,819	$	492,089	$	480,266
Previous periods	36,401		17,249		57,574
Total net revenues	$	605,220	$	509,338	$	537,840

Schedule of Contract with Customer, Contract Asset, Contract Liability, and Receivable

The following table provides information about trade receivables, unbilled receivables and contract liabilities from contracts with customers::

	December 31,
	2024		2023
Trade receivables	$	68,501	$	56,970
Unbilled receivables	$	5,725	$	4,251
Deferred revenues (short-term contract liabilities)	$	(14,225)	$	(16,224)